SMTL ID : 9fmm.2 (1 other biounit)

Structure of human ACE2 in complex with a fluorinated small molecule inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 3 residues within 4Å: Chain A: F.267, N.414, W.576 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:F.267 NAG.3: 5 residues within 4Å: Chain A: D.118, N.141, N.672, S.674, D.675 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.141 NAG.5: 1 residues within 4Å: Chain A: N.72 No protein-ligand interaction detected (PLIP)

1 x 01: (2~{S})-2-[[(2~{S})-3-[3-[(3-chloranyl-5-fluoranyl-phenyl)methyl]imidazol-4-yl]-1-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-4-methyl-pentanoic acid

01.2: 14 residues within 4Å: Chain A: R.255, H.327, P.328, T.329, D.350, T.353, H.356, E.357, H.360, E.384, H.487, Y.492, Y.497 Ligands: ZN.12 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:P.328, A:T.329, A:Y.492 Hydrogen bonds: A:H.327, A:P.328 Salt bridges: A:R.255, A:H.327, A:H.356, A:H.360, A:H.487

4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.4: 4 residues within 4Å: Chain A: N.116, P.117, E.142, W.145 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.116 Water bridges: A:N.116 EDO.6: 9 residues within 4Å: Chain A: A.135, N.136, S.137, L.138, R.143, G.250, N.259, L.260, S.262 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.262, A:S.262 Water bridges: A:R.143, A:L.248 EDO.7: 5 residues within 4Å: Chain A: I.600, K.601, R.603, R.679, E.683 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.603, A:R.679, A:E.683, A:E.683 EDO.8: 6 residues within 4Å: Chain A: Y.181, W.185, D.491, Y.492, S.493, R.496 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.493

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.9: 4 residues within 4Å: Chain A: R.151, W.459, W.460, D.481 Ligand excluded by PLIP CL.10: 3 residues within 4Å: Chain A: D.332, F.372, R.375 Ligand excluded by PLIP

1 x NA: SODIUM ION(Non-functional Binders)

NA.11: 8 residues within 4Å: Chain A: M.134, R.143, A.246, H.247, L.248, L.249, G.250, D.251 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.143, A:H.247, A:L.249, A:G.250

1 x ZN: ZINC ION(Non-covalent)

ZN.12: 5 residues within 4Å: Chain A: H.356, E.357, H.360, E.384 Ligands: 01.2 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.356, A:H.360, A:E.384

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, J. et al., Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2. Eur J Nucl Med Mol Imaging (2024)

Release Date

2024-07-17

Peptides

Angiotensin-converting enzyme 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Angiotensin-converting enzyme 2

Related Entries With Identical Sequence